{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:40:36Z","timestamp":1786736436830,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Androl"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/aja.aja_61_19","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T08:00:55Z","timestamp":1561449655000},"page":"265","source":"Crossref","is-referenced-by-count":29,"title":["Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction"],"prefix":"10.4103","volume":"22","author":[{"given":"Mario","family":"Maggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rastrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1008-682X.261213-1","first-page":"1810\u20138","article-title":"Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study","author":"Tajar","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.261213-2","first-page":"121\u201330","article-title":"Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations","author":"Wang","year":"2009","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.261213-3","first-page":"123\u201335","article-title":"Identification of late-onset hypogonadism in middle-aged and elderly men","author":"Wu","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1008-682X.261213-4","first-page":"1715\u201344","article-title":"Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.261213-5","first-page":"3172\u201382","article-title":"Development of and recovery from secondary hypogonadism in aging men: prospective results from the EMAS","author":"Rastrelli","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.261213-6","first-page":"473\u201384","article-title":"How to define hypogonadism.Results from a population of men consulting for sexual dysfunction?","author":"Rastrelli","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"key-10.4103\/1008-682X.261213-7","first-page":"459\u201369","article-title":"Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: prospective results from the EMAS","author":"Rastrelli","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1008-682X.261213-8","first-page":"891\u2013901","article-title":"Natural history, risk factors and clinical features of primary hypogonadism in ageing men: longitudinal data from the European Male Ageing Study","author":"Ahern","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1008-682X.261213-9","first-page":"369\u201386","article-title":"Lessons from the testosterone trials","author":"Snyder","year":"2018","journal-title":"Endocr Rev"},{"key":"key-10.4103\/1008-682X.261213-10","first-page":"1000\u201311","article-title":"Meta-analysis of results of testosterone therapy on sexual function based on international index of erectile function scores","author":"Corona","year":"2017","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.261213-11","first-page":"197\u2013203","article-title":"A chronic disease score from automated pharmacy data","author":"Von","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"key-10.4103\/1008-682X.261213-12","first-page":"483\u201393","article-title":"Utility of the chronic disease score and Charlson comorbidity index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms","author":"McGregor","year":"2005","journal-title":"Am J Epidemiol"},{"key":"key-10.4103\/1008-682X.261213-13","first-page":"2737\u201345","article-title":"Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study","author":"Wu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.261213-14","first-page":"210\u201320","article-title":"Structured interview on erectile dysfunction (SIEDY\u00a9): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction","author":"Petrone","year":"2003","journal-title":"Int J Impot Res"},{"key":"key-10.4103\/1008-682X.261213-15","first-page":"706\u201315","article-title":"ANDROTEST\u00a9: a structured interview for the screening of hypogonadism in patients with sexual dysfunction","author":"Corona","year":"2011","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.261213-16","first-page":"3666\u201372","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.261213-17","first-page":"173\u201386","article-title":"Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors","author":"Rastrelli","year":"2014","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.261213-18","doi-asserted-by":"crossref","unstructured":"Crown S, Crisp AH. A short clinical diagnostic self-rating scale for psychoneurotic patients. The Middlesex Hospital Questionnaire (M.H.Q.). Br J Psychiatry 1966; 112: 917\u201323.","DOI":"10.1192\/bjp.112.490.917"},{"key":"key-10.4103\/1008-682X.261213-19","first-page":"581\u201391","article-title":"Erectile dysfunction and central obesity: an Italian perspective","author":"Corona","year":"2014","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.261213-20","first-page":"1347\u201358","article-title":"High triglycerides predicts arteriogenic erectile dysfunction and major adverse cardiovascular events in subjects with sexual dysfunction","author":"Corona","year":"2016","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.261213-21","first-page":"1010\u20136","article-title":"Minimal clinically important differences in the erectile function domain of the international index of erectile function scale","author":"Rosen","year":"2011","journal-title":"Eur Urol"},{"key":"key-10.4103\/1008-682X.261213-22","first-page":"302\u201312","article-title":"Effect of testosterone treatment on adipokines and gut hormones in obese men on a hypocaloric diet","author":"Ng","year":"2017","journal-title":"J Endocr Soc"},{"key":"key-10.4103\/1008-682X.261213-23","first-page":"86775","article-title":"Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men","author":"Katznelson","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/1008-682X.261213-24","first-page":"120\u201333","article-title":"Obesity and late-onset hypogonadism","author":"Corona","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"key-10.4103\/1008-682X.261213-25","first-page":"2049\u201357","article-title":"Hypogonadism, decreased sexual desire, and long-term depression in middle-aged men","author":"Hintikka","year":"2009","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.261213-26","first-page":"1753\u201360","article-title":"High rates of depression and depressive symptoms among men referred for borderline testosterone levels","author":"Westley","year":"2015","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.261213-27","first-page":"458\u201368","article-title":"Association between psychiatric symptoms and erectile dysfunction","author":"Corona","year":"2008","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.261213-28","doi-asserted-by":"crossref","first-page":"e015284","DOI":"10.1136\/bmjopen-2016-015284","article-title":"Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis","author":"Elliott","year":"2017","journal-title":"BMJ Open"},{"key":"key-10.4103\/1008-682X.261213-29","first-page":"19\u201332","article-title":"Impact of exogenous testosterone on mood: a systematic review and meta-analysis of randomized placebo-controlled trials","author":"Amanatkar","year":"2014","journal-title":"Ann Clin Psychiatry"},{"key":"key-10.4103\/1008-682X.261213-30","first-page":"1395\u2013407","article-title":"The role of somatic symptoms in sexual medicine: somatization as important contextual factor in male sexual dysfunction","author":"Fanni","year":"2016","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.261213-31","first-page":"687\u2013701","article-title":"Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study","author":"Corona","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/1008-682X.261213-32","first-page":"3007\u201319","article-title":"Endogenous testosterone and mortality in men: a systematic review and meta-analysis","author":"Araujo","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.261213-33","first-page":"1357\u201366","article-title":"Late-onset hypogonadism and mortality in aging men","author":"Pye","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1008-682X.261213-34","first-page":"460\u201370","article-title":"Plasma levels of estradiol, testosterone, and DHEAS do not predict risk of coronary artery disease in men","author":"Contoreggi","year":"1990","journal-title":"J Androl"},{"key":"key-10.4103\/1008-682X.261213-35","first-page":"176\u201384","article-title":"Endogenous sex hormones and cardiovascular disease incidence in men","author":"Arnl\u00f6v","year":"2006","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1008-682X.261213-36","first-page":"435\u201342","article-title":"Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Troms\u00f8 study","author":"Vikan","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/1008-682X.261213-37","first-page":"E321\u201330","article-title":"Predicting low testosterone in aging men: a systematic review","author":"Millar","year":"2016","journal-title":"CMAJ"},{"key":"key-10.4103\/1008-682X.261213-38","first-page":"1184\u201393","article-title":"Erectile dysfunction is common among men with acromegaly and is associated with morbidities related to the disease","author":"Lotti","year":"2015","journal-title":"J Sex Med"},{"key":"key-10.4103\/1008-682X.261213-39","first-page":"695\u2013708","article-title":"Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry","author":"Rastrelli","year":"2016","journal-title":"J Endocrinol Invest"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:41:47Z","timestamp":1786732907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aja.aja_61_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["261213"],"URL":"https:\/\/doi.org\/10.4103\/aja.aja_61_19","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}